FI913625A0 - Behandling av nedsatt funktion av leukocyter med gm-csf. - Google Patents

Behandling av nedsatt funktion av leukocyter med gm-csf.

Info

Publication number
FI913625A0
FI913625A0 FI913625A FI913625A FI913625A0 FI 913625 A0 FI913625 A0 FI 913625A0 FI 913625 A FI913625 A FI 913625A FI 913625 A FI913625 A FI 913625A FI 913625 A0 FI913625 A0 FI 913625A0
Authority
FI
Finland
Prior art keywords
csf
nedsatt
leukocyter
behandling
funktion
Prior art date
Application number
FI913625A
Other languages
English (en)
Finnish (fi)
Inventor
Eric M Bonnem
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI913625A0 publication Critical patent/FI913625A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
FI913625A 1989-01-30 1991-07-30 Behandling av nedsatt funktion av leukocyter med gm-csf. FI913625A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30439189A 1989-01-30 1989-01-30
PCT/US1990/000379 WO1990008554A1 (fr) 1989-01-30 1990-01-26 Traitement de dysfonctionnement leucocytaire a l'aide de gm-csf

Publications (1)

Publication Number Publication Date
FI913625A0 true FI913625A0 (fi) 1991-07-30

Family

ID=23176323

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913625A FI913625A0 (fi) 1989-01-30 1991-07-30 Behandling av nedsatt funktion av leukocyter med gm-csf.

Country Status (21)

Country Link
US (1) US5178855A (fr)
EP (2) EP0382381B1 (fr)
JP (1) JPH0651640B2 (fr)
KR (1) KR0137361B1 (fr)
AT (1) ATE89737T1 (fr)
AU (1) AU633054B2 (fr)
CA (1) CA2045605C (fr)
DE (1) DE69001686T2 (fr)
DK (1) DK0382381T3 (fr)
ES (1) ES2055314T3 (fr)
FI (1) FI913625A0 (fr)
HK (1) HK46196A (fr)
HU (1) HU207229B (fr)
IE (1) IE64234B1 (fr)
IL (1) IL93219A (fr)
MY (1) MY105798A (fr)
NZ (1) NZ243953A (fr)
OA (1) OA09509A (fr)
PT (1) PT92995B (fr)
WO (1) WO1990008554A1 (fr)
ZA (1) ZA90600B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1462392A (en) * 1991-02-22 1992-09-15 Amgen, Inc. Use of gm-csf and g-csf to promote accelerated wound healing
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
EP0661057A4 (fr) * 1993-06-08 1997-09-03 Ajinomoto Kk Accelerateur de la proliferation des cellules hematopietiques.
EP0791061A4 (fr) * 1994-03-04 1998-07-15 Ludwig Inst Cancer Res Animaux a rupture genique ciblee
US5942253A (en) 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US6753165B1 (en) * 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
EP2124897A4 (fr) * 2006-12-22 2012-05-09 Novadel Pharma Inc Préparations antinauséeuses à pulvériser, à usage oral, stables, et méthodes associées
US7648379B2 (en) 2007-08-09 2010-01-19 Haworth, Inc. Modular electrical distribution system for a building

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
AU606585B2 (en) * 1985-10-03 1991-02-14 Biogen, Inc. Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
ATE79761T1 (de) * 1985-11-27 1992-09-15 Genetics Inst Behandlung einer krankheit vom aids-typ.
EP0307402B1 (fr) * 1986-05-06 1993-08-11 Genetics Institute, Inc. Production de m-csf
US5162111A (en) * 1986-07-30 1992-11-10 Grabstein Kenneth H Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
EP0276846A3 (fr) * 1987-01-29 1989-07-26 Zymogenetics, Inc. Dérivés du facteur stimulant des colonies
IL88344A (en) * 1987-11-12 1994-06-24 Schering Corp Accelerating bone formation using a factor that accelerates colonies of granulocyte macrophages

Also Published As

Publication number Publication date
KR910700069A (ko) 1991-03-13
AU5048890A (en) 1990-08-24
DK0382381T3 (da) 1993-07-12
JPH03504980A (ja) 1991-10-31
HU207229B (en) 1993-03-29
CA2045605A1 (fr) 1990-07-31
IL93219A (en) 1998-12-27
IE64234B1 (en) 1995-07-26
EP0382381A1 (fr) 1990-08-16
WO1990008554A1 (fr) 1990-08-09
ATE89737T1 (de) 1993-06-15
IL93219A0 (en) 1990-11-05
NZ243953A (en) 1997-06-24
DE69001686D1 (de) 1993-07-01
PT92995B (pt) 1995-12-29
DE69001686T2 (de) 1993-09-02
AU633054B2 (en) 1993-01-21
IE900318L (en) 1990-07-30
OA09509A (en) 1992-11-15
CA2045605C (fr) 1997-02-11
HUT57607A (en) 1991-12-30
KR0137361B1 (ko) 1998-04-25
ZA90600B (en) 1990-10-31
ES2055314T3 (es) 1994-08-16
MY105798A (en) 1995-01-30
JPH0651640B2 (ja) 1994-07-06
EP0382381B1 (fr) 1993-05-26
US5178855A (en) 1993-01-12
PT92995A (pt) 1990-07-31
HK46196A (en) 1996-03-22
EP0455726A1 (fr) 1991-11-13

Similar Documents

Publication Publication Date Title
PT911033E (pt) Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral
FI103180B1 (fi) Flurbiprofeenia sisältävien lääkkeiden valmistus kipujen ja/tai tulehdusten torjumiseksi eläimissä ja ihmisissä
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
EP0377520A3 (fr) Utilisation de la nicotine pour la fabrication d'un kit utilisé dans le traitement des maladies susceptibles de ce traitement
FI913625A0 (fi) Behandling av nedsatt funktion av leukocyter med gm-csf.
EP0317568A4 (fr) Utilisation de stimulation de colonies de granulocytes-macrophage pour l'obtention d'un médicament pour le traitement de maladies bacteriènnes.
KR890001580A (ko) B형 간염 바이러스에 의해 유발되는 염증 질환을 치료하는 이중가닥 rna를 함유하는 약물
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
IE890580L (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
DK148890D0 (da) Farmaceutisk praeparat
KR870010871A (ko) 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법
EP0397211A3 (fr) Administration percutanée de la 3'-azido-3'-déoxythymidine
Ringsdorf Jr et al. Ascorbic acid and glaucoma: a review
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
Zhang The clinical study of cefamandole nafate.

Legal Events

Date Code Title Description
FD Application lapsed